SEC Form 4/A · accession 0001434316-15-000005
FATE THERAPEUTICS INC · FATE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Amir Nashat
Director · 10% Owner
Period of report
May 13, 2015
Accepted (ET)
May 18, 2015 · 1:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3,F2,F1 | $7.08 | May 13, 2015 | A | 10,000 | A | — | May 12, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The shares subject to this option shall vest and become exercisable on the earlier of (i) May 13, 2016 or (ii) the date of the 2016 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors.
- F2Not Applicable.
- F3This amended filing is being submitted to correct the Reporting Person's address and signature on the initial Form 4 filing, effective May 13, 2015, and the transaction is not new or revised but is being reported again to gain access to the system.